Department of Molecular and Cellular Biochemistry, Center for Molecular Neurobiology, The Ohio State University, Columbus, USA.
Neuropathol Appl Neurobiol. 2011 Apr;37(3):295-306. doi: 10.1111/j.1365-2990.2010.01135.x.
Granulovacuolar degeneration involves the accumulation of large, double membrane-bound bodies within certain neurones during the course of Alzheimer's disease (AD) and other adult-onset dementias. Because of the two-layer membrane morphology, it has been proposed that the bodies are related to autophagic organelles. The aim of this study was to test this hypothesis, and determine the approximate stage at which the pathway stalls in AD.
Spatial colocalization of autophagic and endocytic markers with casein kinase 1 delta, a marker for granulovacuolar degeneration (GVD) bodies, was evaluated in hippocampal sections prepared from post mortem Braak stage IV and V AD cases using double-label confocal fluorescence microscopy.
GVD bodies colocalized weakly with early-stage autophagy markers LC3 and p62, but strongly with late-stage marker lysosome-associated membrane protein 1 (LAMP1), which decorated their surrounding membranes. GVD bodies also colocalized strongly with charged multivesicular body protein 2B (CHMP2B), which colocalized with the core granule, but less strongly with lysosomal marker cathepsin D.
The resultant immunohistochemical signature suggests that granulovacuolar degeneration bodies (GVBs) do contain late-stage autophagic markers, and accumulate at the nexus of autophagic and endocytic pathways. The data further suggest that failure to complete autolysosome formation may be an important correlate of GVB accumulation.
颗粒空泡变性是指在阿尔茨海默病(AD)和其他成人发病性痴呆等疾病过程中,某些神经元内积累大的、双层膜包裹的体。由于双层膜形态,有人提出这些体与自噬细胞器有关。本研究旨在验证这一假说,并确定 AD 中该途径停滞的大致阶段。
使用双标记共聚焦荧光显微镜,在死后 Braak 阶段 IV 和 V AD 病例的海马切片中,评估自噬和内吞标记物与颗粒空泡变性(GVD)体标志物酪蛋白激酶 1 德尔塔(casein kinase 1 delta)的空间共定位。
GVD 体与早期自噬标记物 LC3 和 p62 弱共定位,但与晚期标记物溶酶体相关膜蛋白 1(lysosome-associated membrane protein 1,LAMP1)强共定位,后者修饰其周围膜。GVD 体还与带电荷的多泡体蛋白 2B(charged multivesicular body protein 2B,CHMP2B)强共定位,后者与核心颗粒共定位,但与溶酶体标记物组织蛋白酶 D 弱共定位。
免疫组织化学特征表明,颗粒空泡变性体(GVBs)确实包含晚期自噬标记物,并在自噬和内吞途径的交汇点积累。数据进一步表明,未能完成自溶酶体形成可能是 GVB 积累的一个重要相关因素。